IP Library Granted Patent US 9,547,017
Granted Patent B2
US 9,547,017 · App. 14/384,464 · Granted Jan 17, 2017

Genetically encoded fluorescent sensors for detecting intracellular signalling through diacylglycerol pathways

Inventors: Thomas E. Hughes (Bozeman, MT); Paul H. Tewson (Bozeman, MT); Anne Marie Quinn (Bozeman, MT)
Assignee: Montana Molecular LLC
G01N33/92C07K14/00C12N9/12C12N9/1205G01N33/582C07K2319/60C12Y207/11013
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,547,017
App. No.
14/384,464
Granted
Jan 17, 2017
Kind
B2
Abstract

Described herein are novel fluorescent sensors for Diacyl Glycerol (DAG) and hosphatidylinositol 4,5-bisphosphate (PIP2) that are based on circularly permuted fluorescent proteins. These sensors use less visible spectrum than FRET-based sensors, produce robust changes in fluorescence, and can be combined with one another, or with other sensors, in a multiplex assay on standard fluorescent plate readers or live cell imaging systems.

Claims (22)

1. A diacylglycerol (DAG) sensor fusion protein comprising

a. a protein kinase C (PKC) protein comprising a DAG binding domain and a fusion region, and

b. a circularly permuted fluorescent protein,

wherein the fusion region is located between the pseudo substrate domain and the DAG binding domain, or within the DAG binding domain;

wherein the fluorescent protein is fused with the PKC protein at a fusion site present within the fusion region;

and wherein the fluorescence of the DAG sensor fusion protein changes upon binding to DAG.

2. The DAG sensor fusion protein of claim 1 , wherein the PKC protein is selected from the group consisting of PKC-δ (delta), PKC-ε (epsilon), PKC-θ (theta), PKC-η (eta), PKC-α (alpha), PKC-β1 (beta 1), PKC-β11 (beta 11), PKC-γ (gamma), and PKC-ξ (zeta).

3. The DAG sensor fusion protein of claim 1 , wherein the PKC protein is selected from the group consisting of PKC-δ (delta), PKC-ε (epsilon), PKC-θ (theta) and PKC-η (eta).

4. The DAG sensor fusion protein of claim 1 , wherein the fusion region comprises additions or deletions of amino acids.

5. The DAG sensor fusion protein of claim 1 , wherein the fusion region further comprises linker sequences.

6. The DAG sensor fusion protein of claim 1 , comprising an amino acid sequence that is at least 90% identical to an amino acid sequence selected from the group consisting of SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:9, SEQ ID NO:10, SEQ ID NO:11, SEQ ID NO:12, SEQ ID NO:13, SEQ ID NO:14, SEQ ID NO:15, SEQ ID NO:16, SEQ ID NO:17, SEQ ID NO:18, SEQ ID NO:19, SEQ ID NO:20, SEQ ID NO:21, SEQ ID NO:22, SEQ ID NO:23, SEQ ID NO:24, SEQ ID NO:25, SEQ ID NO:26, SEQ ID NO:27, SEQ ID NO:28, SEQ ID NO:29, SEQ ID NO:30, SEQ ID NO:31, SEQ ID NO:32, SEQ ID NO:33, SEQ ID NO:34, SEQ ID NO:35, and SEQ ID NO:36.

7. The DAG sensor fusion protein of claim 1 , comprising an amino acid sequence that is at least 90% identical to an amino acid sequence selected from the group consisting of SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:12, SEQ ID NO:15, SEQ ID NO:16, SEQ ID NO:17, SEQ ID NO:20, SEQ ID NO:21, SEQ ID NO: 22, SEQ ID NO:24, SEQ ID NO:30.

8. A multiplex system for detecting one or more analytes comprising the DAG sensor fusion protein of claim 1 , and one or more additional fluorescent sensor that specifically detects an analyte other than DAG, wherein the one or more additional fluorescent sensor comprises a) a fluorescent sensor fusion protein comprising a fluorescent protein, or b) a fluorescent dye.

9. The multiplex system of claim 8 , wherein the DAG sensor fusion protein comprises a fluorescent protein that is fluorescent in one region of the spectrum and the additional fluorescent sensor is fluorescent in another region of the spectrum.

10. The multiplex system of claim 8 , wherein the additional fluorescent sensor is

a. a phosphatidylinositol biphosphate (PIP2) sensor, wherein the fluorescence of the PIP2 sensor changes upon binding to PIP2, or

b. a Calcium sensor, wherein the fluorescence of the Calcium sensor changes upon binding to Calcium, or

c. both.

11. A nucleic acid molecule encoding the DAG sensor fusion protein of claim 1 .

12. A cell comprising the nucleic acid molecule of claim 11 .

13. The cell of claim 12 , wherein the nucleic acid molecule encoding the DAG sensor fusion protein is located in the genome of the cell.

14. The cell of claim 12 , further comprising one or more additional nucleic acid molecules that encode one or more additional fluorescent sensor proteins that specifically detect an analyte other than DAG.

Assignments (3)
CONFIRMATORY LICENSE Recorded Jul 24, 2023
From: MONTANA MOLECULAR LLC
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 064366/0535 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 6, 2015
From: HUGHES, THOMAS H.; TEWSON, PAUL H.; QUINN, ANNE MARIE
To: MONTANA MOLECULAR LLC
Reel/Frame 035101/0401 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 15, 2014
From: HUGHES, THOMAS E.; TEWSON, PAUL H.; QUINN, ANNE MARIE
To: MONTANA MOLECULAR LLC
Reel/Frame 033743/0373 →
Continuity (2)
Provisional Application 61611406 · Mar 15, 2012
Related Publication 20160003854A1 · Jan 7, 2016